Moreover, in an acute neurodegenerative mouse model, administration of a combination of a TNFR1 antagonist (ATROSAB) and a TNFR2 agonist (EHD2-scTNFR2) was protective against excitotoxicity and rescued cognitive impairments (17). Here, TNFRSF1B is linked to Cognitive impairment.